Taken together, exogenous α-KG treatment mimics genetic disruption of the TCA cycle by DLST inactivation, leading to increased transcript and protein levels of IDH1 and IDH2 in human T-ALL cells. Here, IDH1 is linked to acute lymphoblastic leukemia.